Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CXCL13 anticorps

CXCL13 Reactivité: Souris WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN110568
  • Antigène Voir toutes CXCL13 Anticorps
    CXCL13 (Chemokine (C-X-C Motif) Ligand 13 (CXCL13))
    Reactivité
    • 39
    • 20
    • 4
    Souris
    Hôte
    • 41
    • 4
    • 1
    • 1
    Lapin
    Clonalité
    • 43
    • 4
    Polyclonal
    Conjugué
    • 25
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CXCL13 est non-conjugé
    Application
    • 41
    • 19
    • 14
    • 14
    • 11
    • 7
    • 6
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Top Product
    Discover our top product CXCL13 Anticorps primaire
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Stock
    4 °C
  • Gunn, Ngo, Ansel, Ekland, Cyster, Williams: "A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1." dans: Nature, Vol. 391, Issue 6669, pp. 799-803, (1998) (PubMed).

  • Antigène
    CXCL13 (Chemokine (C-X-C Motif) Ligand 13 (CXCL13))
    Autre désignation
    BLC (B-Lymphocyte Chemoattractant) (CXCL13 Produits)
    Synonymes
    anticorps 4631412M08Rik, anticorps ANGIE2, anticorps Angie, anticorps BCA-1, anticorps BLC, anticorps BLR1L, anticorps Scyb13, anticorps ANGIE, anticorps BCA1, anticorps SCYB13, anticorps C-X-C motif chemokine ligand 13, anticorps chemokine (C-X-C motif) ligand 13, anticorps Cxcl13, anticorps CXCL13
    Sujet
    BLC (B-lymphocyte chemoattractant, murine equivalent of human B cell-attracting chemokine-1, BCA-1) is a 12 kDa, recently characterized ELR-CXC chemokine. BLC showed high levels of expression in spleen, Peyer's patches, and mesenteric lymph nodes. It is reported as the ligand of CXCR5. It attracts primarily B cells in vitro. Cell lines transfected with CXCR5 demonstrate both chemotaxisand calcium flux in response to BLC.
Vous êtes ici:
Support technique